{
    "SPADE_N_13972": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13972",
            "Peptide Name": "Gj-CATH2 (RA-48, gecko cathelicidin, natural AMPs, Lys-rich; Gekko, reptiles, animals, UCLL1)",
            "Source": "Gekko japonicus,",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLLSGGGSNIAHGPGGRRHIA",
            "Sequence Length": 48,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 5188.31,
            "PI": 12.0,
            "Hydrophobicity": -0.69,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Cai S, Meng K, Liu P, Cao X, Wang G. 2021",
                    "Reference": "Arch Oral Biol. 2021 Sep;129:105205. doi: 10.1016/j.archoralbio.2021.105205.PubMed.",
                    "Title": "Suppressive effects of gecko cathelicidin on biofilm formation and cariogenic virulence factors of Streptococcus mutans."
                }
            ],
            "Frequent Amino Acids": "KGI",
            "Absent Amino Acids": "CDMOQTUWY",
            "Basic Residues": 19,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 16,
            "Polar Residues": 27,
            "Positive Residues": 19,
            "Negative Residues": 1,
            "Net Charge": 18,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (45.1%) toC. mydas cathelicidin 1K: 27%; G: 19%; I: 15%. GRAVY: -0.69; M Wt: 5188.34; M formula: C234H419N77O54.Activity: Active against Gram- E. coli ATCC8739 (MIC 2 ug/ml), S. typhimurium ATCC14028 (MIC 8 ug/ml), K. pneumoniae CMCC46117 (MIC 16 ug/ml), P. aeruginosa CMCC10104 (MIC 16 ug/ml), Gram+ S. aureus CMCC26003 or ATCC 43300 (MIC 16-64 ug/ml) MRSA 64 ug/ml; S. mutans ATCC 700610 UA159 (MIC 4 ug/ml). It also inhihited biofilm formation and expression of virulence factors.Toxicity: caused 6.46% and 4.29% cell death of HaCat and RAW 264.7 cells, respectively, when treated at 100 ug/ml. Sheep:RBC: extremely low hemo.lytic at 100 ug/ml (1.46%).Peptide stability: remained potent after 6 h incubation with saliva. After 24 h incubation, MIC increased to 42 uM, indicating protease cleavage.Structure:  random coil in water and helical in SDS.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14551",
                    "Similarity": 1.0,
                    "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLL"
                },
                {
                    "SPADE_ID": "SPADE_N_14552",
                    "Similarity": 1.0,
                    "Sequence": "RRGIKKFIKKVKKVKKAI"
                },
                {
                    "SPADE_ID": "SPADE_UN_26657",
                    "Similarity": 1.0,
                    "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLL"
                }
            ]
        }
    }
}